tACS for neuropathic pain after spinal cord injury
Official title: tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments
Run by The University of Texas Health Science Center, Houston · NCT06029075 · Data updated 2026-11-12
Researchers are testing whether transcranial alternating current stimulation (tACS) can help manage neuropathic pain in people who have had a spinal cord injury.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 14 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | September 30, 2027 |
| Study ends | March 31, 2028 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT06029075 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–75 with chronic neuropathic pain after SCI (or similar injuries) who are stable on pain medications for at least two weeks.
✕Probably not a fit
Individuals with non-neuropathic pain, recent changes in pain meds, or certain implants may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests different tACS settings to see if they reduce neuropathic pain in adults with spinal cord injury. Participants will be assigned to sham stimulation, 10 Hz tACS, or 20 Hz tACS to compare pain outcomes. The trial will start with SCI patients and may expand to other populations if feasible. Eligible participants are adults ages 18–75 with chronic neuropathic pain lasting more than 3 months who are stable on oral pain medications. Key exclusions include non-neuropathic pain, pacemakers or implants, arm amputations, inability to follow commands, or recent changes in pain therapy.
Why it matters
Potential benefit: If successful, participants could experience reductions in neuropathic pain and improved quality of life.
How similar studies have gone: Previous neuromodulation studies show potential for pain relief, but results for tACS in this context are exploratory and results have been mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion/exclusion criteria for SCI subjects Inclusion criteria: A patient who 1. has neuropathic pain after traumatic spinal cord injury or amputation or brain injury; 2. has chronic pain, \>3 months; 3. is between 18 to 75 years of age; 4. is stable on oral pain medications at least two weeks. Patients are allowed to continue their pain medications, i.e., no change in pain medications. NOTE: we plan to begin the study with the spinal cord injury (SCI) subject population as a cohort first, then expand to other subject populations Exclusion criteria: Patients will be excluded if they 1. are currently adjusting oral pain medications for their neuropathic pain; 2. have pain, but not neuropathic, e.g., from inflammation at the incision wound of the residual limb or neuroma; 3. have a pacemaker metal implants or supplemental oxygen; 4. have amputation in their arm(s); 5. fail to have a motor contraction in the arm muscles with TMS; 6. are not able to follow commands, or to give consent; 7. have asthma or other pulmonary disease; 8. are not medically stable; 9. have preexisting psychiatric disorders; 10. alcohol or drug abuse.
Where it's running
-
The University of Texas Health Science Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Sheng Li, MD, Ph.D — The University of Texas Health Science Center, Houston
- Study coordinator: Sheng Li, MD, Ph.D
- Email: sheng.li@uth.tmc.edu
- Phone: (713) 797-7125
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Extended-release Pregabalin for nerve pain from diabetes or shingles
This phase 3 study tests an extended-release form of pregabalin to see if it reduces nerve-pain symptoms in adults with diabetic neuropathy or postherpetic neuralgia.
-
High-Intensity Peripheral Magnetic Stimulation for Traumatic Nerve Injury
This study tests whether adding high-intensity peripheral magnetic stimulation to a structured exercise program can reduce pain and improve function for adults with a traumatic peripheral nerve injury.
-
Hematological clues and how patients respond to nerve blocks for neuropathic pain
This study looks at blood inflammation markers to see if they relate to how well people with neuropathic pain respond to sympathetic nerve blocks.
-
Cord plasma eye drops to treat neuropathic corneal pain
This trial will test whether cord plasma eye drops can reduce long-lasting nerve-related corneal pain in people with evidence of corneal nerve damage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.